ARCHIMICA S.p.A

Procos S.p.A. is a wholly owned subsidiary of the Japanese company, CBC Co. Ltd Group, specializing in the development, scale-up and production of Active Pharmaceutical Ingredients (APIs), advanced intermediates and related services for the pharmaceutical industry.

Our core business sectors include custom synthesis and Generic API manufacturing.
The manufacturing site is located in Cameri, Italy. This 110,000 sq. meter, cutting-edge multipurpose plant, fully designed under cGMP compliance, has been successfully audited and approved by the main regulatory authorities including AIFA, FDA and PMDA.

We are a locally rooted company yet part of an international network, with commercial offices in key strategic geographies.

DOTTIKON ES manufactures high-quality performance chemicals, intermediates, and exclusive active pharmaceutical ingredients (APIs) for the world's leading chemical, biotech, and pharmaceutical industry. The company with its production site in Dottikon (Aargau, Switzerland) is specialized in hazardous reactions and positions itself as strategic development and manufacturing partner and performance leader. Its safety culture created over the past 105 years guides the innovative use of hazardous reactions, low-temperature and high-pressure chemistry, as well as continuous processing in order to challenge, tighten, or shorten conventional chemical synthesis routes, improve selectivities, yields, and purities, and reduce waste.

The versatile technology and equipment portfolio is used, maintained, and continuously expanded to design, develop, and optimize chemical processes and technical manufacturing procedures for the rapid scale-up from kilograms to multi-tons in order to produce and deliver the respective market volumes.

DOTTIKON ES' one-site strategy allows reduced decision and communication pathways. This ensures rapid and efficient project development, clear and transparent data and process documentation, and close customer communication.

Pepceuticals Limited, established in 1998, is a specialist British manufacturer of synthetic peptides. We remain dedicated to supplying the Life Science industry with high-quality custom peptides and an antibody manufacturing service. Over the years, Pepceuticals has established a reputation for excellence in the field of peptide synthesis, having developed novel technologies that allow us to prepare complex peptide molecules. We are committed to providing solutions to researchers globally by continuing to increase our development program of large and small synthetic peptide libraries, and enhancing the prospects of obtaining new research candidates.

We provide a comprehensive drug development program that allows us to furnish peptides manufactured under cGMP, from milligram to kilogram quantities and to support all aspects of peptide manufacture. Furthermore, we also have an active program to develop generic peptide active substances (API’s) that cover many different disease areas.

At Pepceuticals, we operate a stringent Pharmaceutical Quality System which verifies that the products we supply meet or exceed industry standards. Pepceuticals holds an API manufacturing licence as granted by the MHRA (Medicines and Healthcare Products Regulatory Agency) and BSI ISO 2001-2015 accreditation from the British Standards Industry (BSI) for our manufacturing practices. Our Quality Control (QC) team, ensure that our instrumentation, operating/ testing, and staff training are maintained and continually updated to achieve these high standards. Our aim is to deliver all our products in a reliable time frame with a full certificate of analysis and supporting data.

We ensure effective project management and good communication with all our clients; from sales to product delivery we aspire to offer a complete solution. We trust that you will enjoy the benefits of working with Pepceuticals, as a reliable, flexible and innovative peptide manufacturer.

ChemCon GmbH - Your Good Manufacturing Partner!
ChemCon is a contract development and manufacturing organization (CDMO) located in Freiburg, Germany. We manufacture drug substances (injectable, ophthalmic, oral, topic grade) and ultra-pure chemicals to your specifications. With multidisciplinary expertise we can meet your individual demands for small-molecule organic APIs, inorganic compounds, polymers, and highly potent or controlled substances. ChemCon’s facilities are optimized for the production of small to medium quantities (g to multi 100 kg per year). This is particularly interesting if you are sourcing APIs for clinical trials or commercial applications (i.e., orphan diseases, oncology, or emergency care) with a low annual demand. We also manufacture excipients, provocation substances, dietary trace elements, diagnostics, delivery agents, or reference standards. Your project will be under one roof from synthesis & process development/establishment all the way to commercial cGMP manufacturing, including full documentation, quality control and regulatory support. We also offer external analytical services, independent from production services. ChemCon looks back on an outstanding inspection history by both the FDA and European health authorities. Find our latest company brochure here: https://bit.ly/35ZQm8t

Impressum:
ChemCon GmbH, Engesserstr. 4b, 79108 Freiburg i.Br.
Phone.: +49 (0)761-5597-0; Fax: +49 (0)761-5597-449
E-Mail: Info@chemcon.com
CEO/President: Dr. Raphael Vogler
Commercial register: HRB 5973
Court of registration: Freiburg
VAT Reg. No: DE812753447

Chiracon GmbH has 20 years of experience in the field of drug synthesis and documentation. As a German, Berlin-Brandenburg based company the company can reliably offer all services possible in the field of synthetic drug development for new or generic products. We specialize in organic synthesis, scale up and production. Furthermore we provide all the documentation needed for active pharmaceutical ingredients (APIs) for clinical trials, and also in order to introduce new APIs to market - ASMF (active substance master files) /DMF (drug master files), Pharmaceutical Quality/CMC (Chemistry, Manufacturing and Controls) /IMPD (Investigational Medicinal Product Dossier). We utilize a management system which is based on an integrated ISO9001 system and includes a GMP environment.